BGI Genomics

24/06/2026

🌱 How do grassland plants survive persistent drought?

👏Thrilled to congratulate our client at Inner Mongolia University on their recent publication in Plant Diversity! Their research on Stipa grandis delivers several major advances in grassland evolutionary genomics and stress adaptation.

⭐️Key Highlights:
• First chromosome-level genome for Stipeae tribe — 1.152 Gb, 22 chromosomes, LAI 27.01 , enabled by integrated DNBSEQ + PacBio HiFi + Hi-C solutions
• Discovery of lineage-specific whole-genome duplication (WGD) — Identified a Stipeae-specific whole-genome duplication (~21–25 Mya) distinct from the ancestral ρ-WGD, with reconstructed chromosomal evolution from 12 ancestral to 22 modern chromosomes
• Decoding multi-layered drought networks — Whole-transcriptome profiling revealed root-biased rapid response via miRNA suppression, plus novel regulatory modules: miRNA-95-3p–ARF, miRNA-7-3p–BRI1, and lncRNA-AGPase switch in starch-sucrose metabolism.

These findings elucidate how a keystone steppe species molecularly adapts to persistent aridification, offering candidate genes and non-coding RNA targets for the development of drought-resilient forage grasses and informing conservation strategies for Eurasian grassland ecosystems.🥳

📖 Read the paper: https://lnkd.in/g_NkY-Uk

23/06/2026

Save the Date! STOC General Meeting 2026 is around the corner! 🌍

Centered on the theme The Future of Spatial Biology, this landmark global summit brings together the entire spatio-temporal omics community.

🗓️ June 29-30, 2026
📍 Human Technopole, Milan, Italy

What to expect:
🔬 Global leaders in spatial biology, spatio-temporal omics, and data science
🧠 Real-world applications in cancer and neuroscience
🌐 A shared roadmap: moving from discussion to collaborative projects and funding pathways

We are delighted to join this premier gathering of the spatial omics community. We will showcase our integrated end-to-end multi-omics solutions, facilitate in-depth technical discussions, and explore new cross-border research collaborations.

Keep an eye out for the full conference agenda and exclusive onsite offerings. We can’t wait to connect with you in Milan this June! 👋

🔗 www.stocgeneralmeeting.com

21/06/2026

BGI Genomics and Universidade Católica de Brasília collaborate to advance colorectal cancer screening in Brazil. 🇧🇷🧬

On June 18, BGI Genomics signed a strategic collaboration agreement with UCB to validate an innovative molecular screening approach for colorectal cancer – marking an important step toward expanding early cancer detection in Latin America

Why this matters:
- is the 3rd most common cancer in Brazil (~45,000 new cases/year)
~2,000 participants will be enrolled in Brazil's Federal District with up to 5 years of follow‑up
- A stool DNA‑based screening test will be compared against – the current gold standard

Beyond the study, the partnership supports: scientific exchange, technology transfer, local capacity building, and population‑based screening strategies.

Read more: https://www.bgi.com/global/news/bgi-genomics-partners-with-ucb-to-advance-colorectal-cancer-screening-in-brazil

19/06/2026

Why is ALS care still fragmented – and how can AI fix it?

As World ALS Day (June 21) approaches, we continue The Doctor's Voice – our expert interview series.
Episode 3 – with Dr. Jiang Haishan, Chief Neurologist at Nanfang Hospital.

ALS genotyping is expanding – but still not universal. Care continuity? Often lost when patients switch institutions.

Dr. Jiang believes AI agents can bring real change to ALS research and patient care.

KnowALS – an AI-powered knowledge assistant developed by BGI Genomics – integrates curated medical knowledge, clinical experience, and research insights into one accessible framework. Designed to bridge silos and support patients and doctors across the entire journey.

For hospitals, neurologists, and diagnostic labs: Standardisation + AI‑driven continuity = better outcomes. The technology is ready. Now we need adoption.

👇 Watch the full episode. Share your thoughts below.

19/06/2026

Why is ALS care still fragmented – and how can AI fix it?

As World ALS Day (June 21) approaches, we continue The Doctor's Voice – our expert interview series.

Episode 3 – with Dr. Jiang Haishan, Chief Neurologist at Nanfang Hospital.

ALS genotyping is expanding – but still not universal. Care continuity? Often lost when patients switch institutions.

Dr. Jiang believes AI agents can bring real change to ALS research and patient care.

KnowALS – an AI-powered knowledge assistant developed by BGI Genomics – integrates curated medical knowledge, clinical experience, and research insights into one accessible framework. Designed to bridge silos and support patients and doctors across the entire journey.

For hospitals, neurologists, and diagnostic labs: Standardisation + AI‑driven continuity = better outcomes. The technology is ready. Now we need adoption.

18/06/2026

Research with Heart: A Family Member’s Journey into ALS Science

As World ALS Day (June 21) approaches, we continue The Doctor's Voice – our expert interview series.

Episode 2 – with Xin Jinge, ALS researcher at Guangzhou Baiyun Hospital.

“At the time I joined this research, I was not in the mindset of a bystander – I was more like a family member, throwing myself into this cause.”

Xin‘s uncle was diagnosed with ALS. She watched his hope rise and fall with each consultation.

“I feel that doing research up to now, after being able to integrate it with clinical practice, I have come to feel that research has warmth to it.”

For pharma, research institutes, and foundations: Research without empathy is just data. Combine multi‑omics with patient‑centric design – and you create real impact.

18/06/2026

Wrapping up BGI Genomics first-ever appearance at AMP Europe 2026 !🧬 We had a wonderful chance to connect with industry experts and partners from around the globe during June 15–17 in Tallinn.🌍

What took center stage at our booth:

🧬 SENTIS™ Oncology Solutions
– Clinical-scenario pipeline providing 196-gene & 689-gene panels for medication guidance
- HRD score testing & 25-gene hereditary cancer panels supporting proactive risk assessment and prevention

🧬 PTseq™ and PMseq™ Infectious Disease Solutions
- Fast, cost-effective detection of common microbes and resistance markers
- Tackle complex, critical infections and unexplained fevers with detection over 36,000 microorganisms.

🧬 SIROmics™ Automated Solution – "Sample In, Report Out" system enables unattended operation, reduces manual errors, and boosts testing throughput and stability for localized labs.

Our Product Manager, Zhang Tingting, also delivered a well-received Innovation Stage talk: "Technical Advances and Clinical Application of BRCA Testing - From PARP Inhibitor Therapy to Population Preventive Screening". The session received great feedback – and we were delighted to see many attendees visit our booth afterward for deeper discussions.

We look forward to continuing collaborations to make precision medicine more accessible and clinical-ready.

Huge thanks to everyone who visited our booth and attended our session! Let's keep pushing boundaries together. 🤝

18/06/2026

BGI Genomics' next‑generation Automated Sample Preparation System MSP‑800 has officially received China Class II medical device registration – with international promotion underway.

This new milestone of BGI Genomics' clinical mass spectrometry automation has four core upgrades driving lab efficiency:

⚡ Extreme Speed – 8‑channel parallel pipetting, 2× faster than previous generation MSP-400
💰 Radical Cost Reduction – Steel needle with inline washing reduces tip consumption; no minimum batch size – run 1 to 96 samples flexibly
🧠 Intelligent Stability – Smart monitoring, automatic error alarms, and built‑in liquid level/dot detection
🛡️ Simple & Safe – Fully enclosed, UV disinfection, touchscreen interface, saves bench space

Building on the MSP‑400, the MSP‑800 completes the "Tube in, Plate out" automated workflow – freeing lab professionals from tedious manual tasks to focus on higher‑value work.

Contact our local team or email [email protected] for a quote.



Learn more 👇

Following dedicated research and rigorous validation, BGI Genomics’ next-generation Automated Sample Preparation System MSP-800 has been officially granted China Class II medical device registration certification and approved for market launch, with simult